Background Reproductive function in women with end stage renal disease generally
improves after kidney transplant. However, pregnancy remains challenging due to the risk of …

Approximately 50 000 women of reproductive age in the United States are currently living
after kidney transplantation (KT), and another 2800 undergo KT each year. Although KT …

Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting
approximately 2% of the world's population. In this guideline, we focus the discussion on …

Background: Psoriasis is a common chronic inflammatory skin disease with an exceptionally
high burden for women. Objective: Sex-dependent differences in disease manifestation …

Antifungal prescription remains a challenge in pregnant women because of uncertainties
regarding fetal toxicity and altered maternal pharmacokinetic parameters that may affect …

Ciclosporin (cyclosporine) is an immunosuppressive drug first approved for use in organ
transplantation to prevent rejection. Ciclosporin is also known to be used for the treatment of …

Fertility rates, pregnancy, and maternal outcomes are not well described among women with
a functioning kidney transplant. Using data from the Australian and New Zealand Dialysis …

Pregnancy is possible in all phases of chronic kidney disease (CKD), but its management
may be difficult and the outcomes are not the same as in the overall population. The …

Reproductive success is a common, expected outcome for male and female recipients of
solid-organ transplants. Men can father children, and women can become pregnant and …

BACKGROUND: Cyclosporine is a valuable option for the treatment of psoriasis. This report
summarizes studies regarding the use of cyclosporine since the last guidelines were …